https://www.selleckchem.com/pr....oducts/elexacaftor.h
Hepatitis C virus (HCV) infection is common. Although treatment is effective, with oral antivirals curing 95% of patients, most individuals have comorbidities that persist long term. Therefore, our aim was to determine the prevalence of potentially modifiable health problems in patients with HCV and develop an HCV care bundle to identify and target comorbidities. Cross-sectional, observational single-centre study that recruited consecutive patients with HCV from our viral hepatitis clinics. Data were collected on cardiovascular
Like
Comment
Share
